Literature DB >> 2946925

[Cilazapril in essential hypertension. A placebo-controlled double-blind study to establish the dosage].

G G Belz, H Lange, W Tschollar, W Neis.   

Abstract

Entities:  

Mesh：

Substances：

Year:  1986        PMID： 2946925

Source DB:  PubMed          Journal:  Med Klin (Munich)        ISSN： 0723-5003


× No keyword cloud information.
  7 in total

Review 1.  Cilazapril. A review of its pharmacodynamic and pharmacokinetic properties, and therapeutic potential in cardiovascular disease.

Authors:  F Deget; R N Brogden
Journal:  Drugs       Date:  1991-05       Impact factor: 9.546

Review 2.  Blood pressure lowering efficacy of angiotensin converting enzyme (ACE) inhibitors for primary hypertension.

Authors:  Balraj S Heran; Michelle My Wong; Inderjit K Heran; James M Wright
Journal:  Cochrane Database Syst Rev       Date:  2008-10-08

3.  A method for estimating the potency of angiotensin-converting enzyme inhibitors in man.

Authors:  A Wellstein; J Essig; G G Belz
Journal:  Br J Clin Pharmacol       Date:  1987-09       Impact factor: 4.335

4.  Antihypertensive effects and pharmacokinetics of single and consecutive doses of cilazapril in hypertensive patients with normal or impaired renal function.

Authors:  H Shionoiri; E Gotoh; K Sugimoto; I Takasaki; K Minamisawa; M Ishii
Journal:  Br J Clin Pharmacol       Date:  1989       Impact factor: 4.335

5.  Pharmacokinetic and pharmacodynamic interactions between the ACE inhibitor cilazapril and beta-adrenoceptor antagonist propranolol in healthy subjects and in hypertensive patients.

Authors:  G G Belz; J Essig; K Erb; K Breithaupt; J F Hoogkamer; J Kneer; C H Kleinbloesem
Journal:  Br J Clin Pharmacol       Date:  1989       Impact factor: 4.335

6.  The influence of prostaglandin inhibition by indomethacin on blood pressure and renal function in hypertensive patients treated with cilazapril.

Authors:  W Kirch; K Stroemer; J F Hoogkamer; C H Kleinbloesem
Journal:  Br J Clin Pharmacol       Date:  1989       Impact factor: 4.335

7.  Interactions between cilazapril and propranolol in man; plasma drug concentrations, hormone and enzyme responses, haemodynamics, agonist dose-effect curves and baroreceptor reflex.

Authors:  G G Belz; J Essig; C H Kleinbloesem; J F Hoogkamer; U W Wiegand; A Wellstein
Journal:  Br J Clin Pharmacol       Date:  1988-11       Impact factor: 4.335
  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.